{
  "id": 18774345,
  "title": "Lp(a)-Lowering Pelacarsen Shows Huge Disconnect With Cardiovascular Outcomes",
  "url": "https://urgent.news/2026/11/07/lp-a-lowering-pelacarsen-shows-huge-disconnect-with-cardiovascular",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-07T18:24:51.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/aha/123771"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Lowering lipoprotein(a), or Lp(a), did not translate into better cardiovascular outcomes in a secondary prevention population, at least not with pelacarsen in the Lp(a) HORIZON trial. Among people with elevated lipoprotein(a...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}